APAXEN
Apaxen is a company that creates anti-inflammatory medicines to treat pulmonary arterial hypertension. The business focuses on finding and creating suitable small molecule inhibitors of macrophage migration inhibitory factor, which is essential for the creation and activation of NLRP3 inflammasomes. Its drug candidate, MFC-1040, is an orally bioavailable and selective small-molecule MIF inhibitor that is being developed to treat pulmonary arterial hypertension, a deadly illness with a medical need because current treatments are symptomatic and have a low median survival rate.
APAXEN
Industry:
Biotechnology Life Science Product Research Wellness
Founded:
2018-01-01
Address:
Gosselies, Hainaut, Belgium
Country:
Belgium
Website Url:
http://www.apaxen.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Official Site Inspections
http://www.apaxen.com
- Host name: cloud01.visible.be
- IP address: 193.105.133.211
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
